Cristina Legnani

St. Orsola Malpighi University Hospital
Bologna, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Selected cell receptor genotypes differentially modulate the ABO blood group influence on Factor VIII levels in severe aortic stenosis.

Selected cell receptor genotypes differentially modulate the ABO blood group influence on Factor VIII levels in severe aortic stenosis.

Journal: Thrombosis research

Published: February 28, 2025

Can the Charlson comorbidity index help to guide DOAC dosing in patients with atrial fibrillation and improve the efficacy and safety of treatment? A subanalysis of the MAS study.

Can the Charlson comorbidity index help to guide DOAC dosing in patients with atrial fibrillation and improve the efficacy and safety of treatment? A subanalysis of the MAS study.

Journal: Current problems in cardiology

Published: October 22, 2024

The use of reduced DOAC doses in atrial fibrillation patients does not always lead to good anticoagulation levels and avoid adverse events.

The use of reduced DOAC doses in atrial fibrillation patients does not always lead to good anticoagulation levels and avoid adverse events.

Journal: International journal of cardiology

Published: June 27, 2024

D-dimer levels in patients with acute venous thromboembolism and occult cancer: the DD-Neo study.

D-dimer levels in patients with acute venous thromboembolism and occult cancer: the DD-Neo study.

Journal: Internal and emergency medicine

Published: April 24, 2024

Sex Differences in Clinical Presentation of Lower Extremity Deep Vein Thrombosis.

Sex Differences in Clinical Presentation of Lower Extremity Deep Vein Thrombosis.

Journal: Journal of women's health (2002)

Published: March 26, 2024

More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study.

More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study.

Journal: Blood advances

Published: March 08, 2024

Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study.

Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study.

Journal: Blood advances

Published: December 14, 2023

D-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical results.

D-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical results.

Journal: Thrombosis research

Published: November 15, 2023

D-Dimers in diagnosis and prevention of venous thrombosis: recent advances and their practical implications.

D-Dimers in diagnosis and prevention of venous thrombosis: recent advances and their practical implications.

Journal: Polish archives of internal medicine

Published: November 15, 2023

Venous Thromboembolism in Women of Childbearing Age: Insights from the START Registry.

Venous Thromboembolism in Women of Childbearing Age: Insights from the START Registry.

Journal: Thrombosis and haemostasis

Published: June 01, 2023

Incidence and clinical outcomes of heparin-induced thrombocytopenia: 11 year experience in a tertiary care university hospital.

Incidence and clinical outcomes of heparin-induced thrombocytopenia: 11 year experience in a tertiary care university hospital.

Journal: Internal and emergency medicine

Published: March 16, 2023

COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study.

COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study.

Journal: Haematologica

Published: October 10, 2022

Showing 1-12 of 76

Last Updated: 09/26/2026